Antiphospholipid Syndrome

Top Story

Direct-to-consumer genetic testing not ready for prime time in rheumatology

Direct-to-consumer genetic testing not ready for prime time in rheumatology
January 18, 2019
In the Journals

Few rheumatic adverse events from immune checkpoint inhibitors require discontinuation

November 15, 2018
Researchers found that the most prevalent adverse effect linked to immune checkpoint inhibitors was inflammatory arthritis, and although most patients received long…
Meeting News

IgG antiphospholipid antibodies linked to heart attack

November 5, 2018
CHICAGO — The presence of IgG antiphospholipid antibodies is strongly and independently associated with myocardial infarction, according to data presented by…

ACR report card: Majority of states score 'C' for rheumatology care

September 4, 2018
The 2018 Rheumatic Disease Report Card: Raising the Grade on Rheumatology Care in America released today by the American College of Rheumatology demonstrates that…
More Headlines »
CME

Multidisciplinary Perspectives in Giant Cell Arteritis: A Team-based Approach for Improved Quality of Care

This activity is supported by an educational grant from Genentech, Inc.

Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. If left untreated, patients…
More »
Video
Meeting News

Genetic testing decoded: Discussing goals, limitations of direct-to-consumer tests

November 1, 2018
More »
CME CME

Latest Developments and Expert Outlook On Management of Psoriatic Arthritis

This activity is supported by independent educational grants from Celgene and Novartis Pharmaceuticals Corporation.

Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal, disabling disease, commonly associated with skin…
More »